Wildy logo
(020) 7242 5778
enquiries@wildy.com

Wildy’s Book News

Book News cover photo

Vol 23 No 4 April/May 2018

Book of the Month

Cover of Williams, Mortimer and Sunnucks: Executors, Administrators and Probate

Williams, Mortimer and Sunnucks: Executors, Administrators and Probate

Edited by: Alexander Learmonth, Charlotte Ford, Julia Clark, John Ross Martyn
Price: £295.00

Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


Lowe legislation jp
Sealy millman 2018 jp
Desmith out now
Uk supremem 1 8
Williams published
Luba housing

UK Public Holiday Monday 28th May

Wildy's will be closed on Monday 28th May, re-opening on Tuesday 29th.

Online book orders received during the time we are closed will be processed as soon as possible once we re-open on Tuesday.

As usual credit cards will not be charged until the order is processed and ready to despatch.

Any Sweet & Maxwell or Lexis eBook orders placed after 4pm on the Friday 25th May will not be processed until Tuesday May 29th. UK orders for other publishers will be processed as normal. All non-UK eBook orders will be processed on Tuesday May 29th.

Hide this message

Bioproperty, Biomedicine and Deliberative Governance: Patents as Discourse on Life (eBook)

Image not available ebook lge

ISBN13: 9781317174189
Published: December 2014
Publisher: Routledge
Country of Publication: UK
Format: eBook (ePub)
Price: £29.99 + £6.00 VAT
The amount of VAT charged may change depending on your location of use.


Once the order is confirmed an automated e-mail will be sent to you to allow you to download the eBook.

All eBooks are supplied firm sale and cannot be returned. If you believe there is a fault with your eBook then contact us on ebooks@wildy.com and we will help in resolving the issue. This does not affect your statutory rights.

This eBook is available in the following formats: ePub.


In stock.
Need help with ebook formats?


Also available as

Biomedical patents have been the subject of heated debate. Regulatory agencies such as the European Patent Office make small decisions with big implications, which escape scrutiny and revision, when they decide who has access to expensive diagnostic tests, whether human embryonic stem cells can be traded in markets, and under what circumstances human health is more important than animal welfare. Moreover, the administration of the Trade Related Aspects of Intellectual Property Rights by the World Trade Organization has raised considerable disquiet as it has arguably created grave health inequities. Those doubting the merits of the one size fits all approach ask whether priority should be given to serving the present needs of populations in dire need of medication or to promoting global innovation.

The book looks in detail into the legal issues and ethical debates to ask the following three main questions: First, what are the ideas, goals, and broader ethical visions that underpin questions of governance and the legal reasoning employed by administrative agencies? Second, how can we democratize the decision making process of technocratic institutions such as the European Patent Office? Finally, how can we make the global intellectual property system more equitable? In answering these questions the book seeks to contribute to our understanding of the role and function of regulatory agencies in the regulation of the bioeconomy, explains the process of interpretation of legal norms, and proposes ways to rethink the reform of the patent system through the lens of legitimacy.

Image not available ebook lge
Subjects:
Intellectual Property Law, Medical Law, eBooks
Contents:
Introduction.

Part I The European Patent Office and the Question of Legitimacy: Morality, Ethics, and Technocracy: The European Patent Office, biotechnology and ethics. Revising ends of policy and rethinking public deliberation
Neutral or practically wise regulator? Genes, patents, and human health
Rethinking multilevel governance in the EU and the future of the EPO. From morality to ethics.

Part II The European Patent Office and Public Bioethics: Public bioethics. Lay opinions, human need and the case of germ line interventions in human embryos
EPO and public bioethics. Germ line interventions in human embryos, the problem of commodification and the question of incentives.

Part III Patents, Global Trade and Bioethics. Rethinking Good Governance: TRIPs, access to medicines, and the global governance of patents. Cultivating humanity and equity
Global health networks and discursive legitimacy
Some reflections on good patent governance
Conclusions: a discursive analysis of patents.

Index.